Determining the Role of Genetic Risk Scores in Symptomatic Cancer Detection

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 2023 Feb 23

PMID 36823064

Authors

Sarah Er Bailey

Celia Am Butler

Evangelos Katsampouris

Larry Kessler

Samantha L Quaife

Sibel Saya

Samuel Wd Merriel

Affiliations

Soon will be listed here.

References

Green H, Merriel S, Oram R, Ruth K, Tyrrell J, Jones S . Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank. Br J Cancer. 2022; 127(8):1534-1539. PMC: 9553867. DOI: 10.1038/s41416-022-01918-z. View

Hippisley-Cox J, Coupland C . Symptoms and risk factors to identify men with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2013; 63(606):e1-10. PMC: 3529287. DOI: 10.3399/bjgp13X660724. View

Helfand B, Kearns J, Conran C, Xu J . Clinical validity and utility of genetic risk scores in prostate cancer. Asian J Androl. 2016; 18(4):509-14. PMC: 4955171. DOI: 10.4103/1008-682X.182981. View

Cerone M, Mills T, Sharpe R, McBride D, MacDonald M, MacMahon S . The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care. Br J Cancer. 2023; 128(2):161-164. PMC: 9902467. DOI: 10.1038/s41416-022-02107-8. View

Fry A, Littlejohns T, Sudlow C, Doherty N, Adamska L, Sprosen T . Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017; 186(9):1026-1034. PMC: 5860371. DOI: 10.1093/aje/kwx246. View

Yanes T, Willis A, Meiser B, Tucker K, Best M . Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review. Eur J Hum Genet. 2018; 27(1):28-35. PMC: 6303287. DOI: 10.1038/s41431-018-0257-5. View

Rashkin S, Graff R, Kachuri L, Thai K, Alexeeff S, Blatchins M . Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020; 11(1):4423. PMC: 7473862. DOI: 10.1038/s41467-020-18246-6. View

Hamilton W . Cancer diagnosis in primary care. Br J Gen Pract. 2010; 60(571):121-8. PMC: 2814263. DOI: 10.3399/bjgp10X483175. View

Green T, Martins T, Hamilton W, Rubin G, Elliott K, Macleod U . Exploring GPs' experiences of using diagnostic tools for cancer: a qualitative study in primary care. Fam Pract. 2014; 32(1):101-5. DOI: 10.1093/fampra/cmu081. View

10.

Hamilton W, Green T, Martins T, Elliott K, Rubin G, Macleod U . Evaluation of risk assessment tools for suspected cancer in general practice: a cohort study. Br J Gen Pract. 2013; 63(606):e30-6. PMC: 3529290. DOI: 10.3399/bjgp13X660751. View

11.

Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S . Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer. 2012; 107(8):1220-6. PMC: 3494426. DOI: 10.1038/bjc.2012.408. View

12.

Conran C, Na R, Chen H, Jiang D, Lin X, Zheng S . Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer. Asian J Androl. 2016; 18(4):520-4. PMC: 4955173. DOI: 10.4103/1008-682X.179527. View